688613 Stock Overview
Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Allgens Medical Technology CO., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.08 |
| 52 Week High | CN¥29.80 |
| 52 Week Low | CN¥12.44 |
| Beta | 0 |
| 1 Month Change | -3.16% |
| 3 Month Change | -26.13% |
| 1 Year Change | -51.35% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -85.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688613 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 8.1% | 6.4% | 2.1% |
| 1Y | -51.3% | -16.8% | -14.2% |
Return vs Industry: 688613 underperformed the CN Medical Equipment industry which returned -18.6% over the past year.
Return vs Market: 688613 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 688613 volatility | |
|---|---|
| 688613 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688613's share price has been volatile over the past 3 months.
Volatility Over Time: 688613's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 151 | n/a | www.allgensmed.cn |
Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers collagen artificial bone repair materials to agents and terminal hospitals.
Allgens Medical Technology CO., LTD. Fundamentals Summary
| 688613 fundamental statistics | |
|---|---|
| Market cap | CN¥1.88b |
| Earnings (TTM) | CN¥42.66m |
| Revenue (TTM) | CN¥226.03m |
44.0x
P/E Ratio8.3x
P/S RatioIs 688613 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688613 income statement (TTM) | |
|---|---|
| Revenue | CN¥226.03m |
| Cost of Revenue | CN¥39.45m |
| Gross Profit | CN¥186.58m |
| Other Expenses | CN¥143.93m |
| Earnings | CN¥42.66m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 82.55% |
| Net Profit Margin | 18.87% |
| Debt/Equity Ratio | 3.5% |
How did 688613 perform over the long term?
See historical performance and comparison